BofA raised the firm’s price target on Eaton (ETN) to $410 from $350 and keeps a Buy rating on the shares after having met with Heath ...

BofA raised the firm’s price target on Salesforce (CRM) to $390 from $325 and keeps a Buy rating on the shares. A round of calls with partners suggests largely in-line deal activity in Q3 and a better ...

The report has led BofA to expect that Amazon could be on track for $3.5 billion to $4 billion in ad revenues in 2025. While ...

A year-end Treasury rally helped Bank of America reduce unrealized losses in its "held-to-maturity" portfolio. When purchasing securities, banks have a choice to either label it available-for-sale ...

Walt Disney (DIS) faces mixed advertising trends but its fiscal 2024 free cash flow outlook surprised to the upside as the company moderates content spending, BofA Securities said in a note Thursday.

Tesla (TSLA, Financial) shares jumped over 9% to $350 on November 11, boosting the company's market cap to more than $1 ...

(Reuters) - Bank of America reported a drop in third-quarter profit on Tuesday, as its income from customer interest payments shrank. Banks have been paying out higher interest rates amid intense ...

Investing.com -- Bank of America raised its price target for Hims&Hers Health to $25 from $23 on Monday, citing strong core sales trends that point to potential upside in third-quarter revenue.

On Monday, BofA Securities updated its outlook on Doximity Inc (NYSE:DOCS), a professional medical network, raising the price target to $45 from the previous $32 while maintaining a Neutral rating on ...

A BofA analyst sees room for Nvidia Corp. shares to tack on another 40% or so to their explosive rally, as a “generational opportunity” further unfolds. BofA’s Vivek Arya upped his price ...

Nvidia stock has much more room to run up its all-time high share price set this week, argue Bank of America analysts ... Nvidia’s sales and net income were 350% and 2,400% higher during ...

On Monday, BofA Securities updated its outlook on Doximity Inc (NYSE:DOCS), a professional medical network, raising the price target to $45 from the previous $32 while maintaining a Neutral rating ...